Leigh MacMillan

March 10, 2025

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.

By Leigh MacMillan
February 3, 2025

Digital pathology aims to unlock secrets hidden in tissue samples

The pilot project, which is expected to digitize 500,000 slides over three years, aims to open avenues for research, assist with access to whole-slide images for education and clinical meetings (of tumor boards, for example), and facilitate planning for the implementation of digital pathology for diagnostic purposes. 

By Leigh MacMillan (video by Erin O. Smith and Donn Jones)
January 23, 2025

Eric Skaar wins National Academy of Sciences award

Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases.”

By Leigh MacMillan
January 10, 2025

STAR Clinical Research Network quarterly update to be Jan. 23

January 10, 2025

MyHealth Bundles program expands to VTHH, VBCH

VUMC health plan members can now access the MyMaternity Health and MyOrthoHealth bundles at Vanderbilt Tullahoma-Harton Hospital in Tullahoma and the MyWeightLoss-Surgical Weight Loss Bundle at Vanderbilt Bedford Hospital in Shelbyville.
December 18, 2024

VUMC part of multisite team investigating genetic markers of anorexia nervosa

With funding from the newly established Sarah Kyle Anorexia Nervosa Research Foundation, the researchers hope to identify biomarkers that will point to novel targets for prevention and treatment.

By Leigh MacMillan
November 26, 2024

What’s all the tuft about?

Vanderbilt researchers used advanced imaging techniques to detail the microscopic structure of intestinal tuft cells, highlighting their unique organization of the structural protein actin.
By Amanda Ruelas
November 26, 2024

Novel genetics approach enhances discovery of disease risk genes

VUMC researchers applied the new approach to large GWAS datasets for breast, prostate and lung cancers, and three brain disorders.
By Leigh MacMillan
November 15, 2024

New radiation therapy approach for treating lung cancers

VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan.
By Mahima Sharma
November 15, 2024

Zinc deficiency promotes Acinetobacter lung infection: study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.
By Leigh MacMillan
November 12, 2024

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.
By Leigh MacMillan
November 8, 2024

In-clinic reconstruction of skin cancer defects costs less than OR procedures

Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.
By Kanchana Devanathan
1 2 3 … 77